SCHEMBL4437313

SCHEMBL4437313

O=C(OC(=O)c1cc(OCc2ccc(Br)cc2Br)ccc1NC(=O)C1CC1)c1cc(OCc2ccc(Cl)cc2Br)ccc1NC(=O)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
ABL1 P00519 4/20 0.40
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
FFAR1 O14842 1/20 0.36
GRM5 P41594 1/20 0.36
F10 P00742 4/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437310 0.92 KDM4E (0.48) KMT2AABL1KDM4EHSD17B10MEN1
SCHEMBL1823212 0.88 KDM4E (0.52) KMT2AABL1KDM4EHSD17B10HPGD
SCHEMBL1825095 0.86 KDM4E (0.54) KMT2AABL1KDM4EHSD17B10SMN1; SMN2
SCHEMBL1824677 0.80 KDM4E (0.52) KMT2AABL1KDM4EHSD17B10SMN1; SMN2
SCHEMBL1825586 0.78 NR4A2 (0.55) KMT2AKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL1823309 0.76 KDM4E (0.52) KMT2AABL1KDM4EHSD17B10SMN1; SMN2
SCHEMBL1823741 0.76 KMT2A (0.58) KMT2AKDM4EHSD17B10ALDH1A1FFAR1
SCHEMBL1826208 0.76 KDM4E (0.52) KMT2AABL1KDM4EHSD17B10MEN1
SCHEMBL1825885 0.74 KDM4E (0.49) KMT2AABL1KDM4EHSD17B10ALDH1A1
SCHEMBL1824122 0.74 KDM4E (0.49) KMT2AKDM4EHSD17B10MEN1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118051-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Chelsea Therapeutics, Inc. (US) 2009-11-18 EP disclosed
WO-2008097180-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF CHELSEA THERAPEUTICS, INC. (US) 2008-08-14 WO disclosed